Skip to main content
AMA Journal of Ethics®
Illuminating the Art of Medicine

Main navigation

  • Issues
  • Articles
  • Cases
  • Art
  • Multimedia
  • CME
  • Topics
  • For Authors
  • Call for Papers
  • Call for Artwork
  • Call for Editorial Fellows
  • Art Collaborations
  • Register for Sep 10 Grand Rounds
  • En Español

Featured Content

Case and Commentary
Apr 2025

¿Cómo deberían proteger los miembros del equipo de cirugía a los pacientes que están privados de libertad de la vigilancia o intrusión de los oficiales del centro penitenciario?

Anna Lin, MD and Mallory Williams, MD, MPH
Case and Commentary
Feb 2025

¿Cómo se debe describir y tratar el dolor causado por la colocación del DIU?

Veronica Hutchison, MD and Eve Espey, MD, MPH

Articles

Article Types
Topics
Core Competencies
Specialties
Language
Reset
  • nlit1-2407
    In the Literature
    Jul 2024

    How Should Harm Reduction Strategies Differ for Adolescents and Adults?

    Brady J. Heward, MD, Amy M. Yule, MD, and Peter R. Jackson, MD
    Recent increases in adolescent mortality from overdose have outpaced increases in mortality in members of the general population.
    AMA J Ethics. 2024;26(7):E534-545. doi: 10.1001/amajethics.2024.534.
  • mhst1-2407
    History of Medicine
    Jul 2024

    Drawing on Black and Queer Communities’ Harm Reduction Histories to Improve Overdose Prevention Strategies and Policies

    Sterling Johnson, JD, MA and Kimberly L. Sue, MD, PhD
    Black and queer community-based harm reduction practices can help guide development and implementation of anti-overdose interventions.
    AMA J Ethics. 2024;26(7):E580-586. doi: 10.1001/amajethics.2024.580.
  • cscm2-2407
    Case and Commentary
    Jul 2024

    When Medication Treatment for Opioid Use Disorder Gets Disrupted by Extra-Clinical Variables, How Should Clinicians Respond?

    Taleed El-Sabawi, JD, PhD and Kelly Gillespie, JD, PhD, RN
    Clinicians caring for patients with OUD should plan for possible disruptions of treatment caused by arrests and pretrial confinements.
    AMA J Ethics. 2024;26(7):E520-526. doi: 10.1001/amajethics.2024.520.
  • msoc1-2407
    Medicine and Society
    Jul 2024

    How Should Harm Reduction Be Included in Care Continua for Patients With Opioid Use Disorder?

    Elizabeth Salisbury-Afshar, MD, MPH, Catherine J. Livingston, MD, MPH, and Ricky N. Bluthenthal, PhD
    Equity requires full access to evidence-based OUD care, housing stability, and education and employment opportunities.
    AMA J Ethics. 2024;26(7):E562-571. doi: 10.1001/amajethics.2024.562.
  • fred1-2407
    From the Editor
    Jul 2024

    Why Harm Reduction and Equity Are Ethical Imperatives in Opioid Use Disorder Care

    Jeremy Weleff, DO
    American OUD care has generated deaths and discriminatory policies that need remediation.
    AMA J Ethics. 2024;26(7):E509-511. doi: 10.1001/amajethics.2024.509.
  • hlaw1-2407
    Health Law
    Jul 2024

    What Should the US Learn From New York’s and Portugal’s Approaches to the Opioid Crisis?

    Maura McGinnity
    Some US localities are trying interventions modeled on international approaches to decriminalization.
    AMA J Ethics. 2024;26(7):E546-550. doi: 10.1001/amajethics.2024.546.
  • vwpt1-2407
    Viewpoint
    Jul 2024

    Opioid Epidemic Grief and Characterological Harm Reduction

    Christy A. Rentmeester, PhD
    Becoming callous, bitter, or resentful are harms we can suffer when grieving losses, especially at epidemic scale.
    AMA J Ethics. 2024;26(7):E587-590. doi: 10.1001/amajethics.2024.587.
  • cscm3-2407
    Case and Commentary
    Jul 2024

    When Are “Paraphernalia” Critical Medical Supplies?

    Adriane M. dela Cruz, MD, PhD, Donald Egan, MD, MPH, Sarah E. Baker, MD, MA, and John Z. Sadler, MD
    Evidence of harm reduction interventions’ morbidity and mortality benefits is abundant and of high quality.
    AMA J Ethics. 2024;26(7):E527-533. doi: 10.1001/amajethics.2024.527.
  • msoc2-2407
    Medicine and Society
    Jul 2024

    What Would Equitable Harm Reduction Look Like?

    Oluwole Jegede, MD, MPH, Julio C. Nunes, MD, Terence Tumenta, MD, MPH, Carmen Black, MD, and Joao P. De Aquino, MD
    Structural determinants of health frameworks must be person centered and express antiracism to be effective.
    AMA J Ethics. 2024;26(7):E572-579. doi: 10.1001/amajethics.2024.572.
  • cscm1-2407
    Case and Commentary
    Jul 2024

    How Should Risks and Benefits of Short-Acting Opioids Be Evaluated in the Care of Inpatients With OUD?

    Kathryn A. Dong, MD, MSc and Katherine M. Duthie, PhD, HEC-C
    Severe withdrawal, risk of patient-initiated discharge, and some inpatients’ uses of substances prompt questions considered in this commentary.
    AMA J Ethics. 2024;26(7):E512-519. doi: 10.1001/amajethics.2024.512.

Pagination

  • First page « First
  • Previous page ‹ Prev
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • …
  • Next page Next ›
  • Last page Last »
AMA Journal of Ethics®
Illuminating the Art of Medicine

Footer menu

  • About
  • Conditions of Use
  • Privacy Policy
  • Website Accessibility
  • FAQ
  • Contact
American Medical Association

Email Signup


We do not share email addresses and will only use yours to send new content alerts. (Add [email protected] to your contacts to help ensure receipt.)
Copyright 2025 American Medical Association. All Rights Reserved. ISSN 2376-6980